
Join Health Initiative for Men (HIM) , PAN and Ribbon Community for an overview of recent changes to the HIV medication landscape in Canada. This webinar will empower frontline staff, educators, and community members with new information on long-acting HIV treatment and prevention options and highlight current realities for accessing long-acting medications for priority populations in BC.
Wednesday July 10th, 2024
10 – 11:30 AM Pacific time
This webinar is scheduled for 90 minutes. Information on presenters to follow. We look forward to seeing you!
This webinar will support the work of:
- frontline service providers
- community educators
- community advocates
- people interested in HIV treatment and advocacy
Please note: As this webinar is being presented in partnership with Health Initiative for Men (HIM) and Ribbon Community, your registration information may be shared with these organizations.
Please read before you register
Group Guidelines:
At all our events, we strive to do our best to create a culturally safe environment, and ask that all participants follow our Group Guidelines and Responsibilities. Review now.
Evaluation
In exchange for this free learning opportunity, we ask all people who take part in our events to complete the evaluation so we may learn about how the work can best support community.
Media Release:
In registering to take part in this event, you acknowledge that PAN is recording this event and that your name, image and voice may be recorded. You give PAN the right and authority to use your name, voice, and image if applicable. PAN will provide information on how to change your name onscreen if you wish, but as with any online platform, we can’t guarantee anonymity.
Save your confirmation
After registration you should receive a confirmation email. SAVE THE CONFIRMATION EMAIL to access webinar. Email [email protected] if this does not arrive.
Register
For additional learning options, visit our library of on-demand webinars in the PAN Presents and KnowledgeConnect series.
We greatly appreciate the vision of our government funders and their ongoing commitment to supporting the work of PAN. In particular we gratefully acknowledge the Public Health Agency of Canada – HIV and Hepatitis C Community Action Fund. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.